an uninterrupted period of twenty years or more. Such employees are entitled to receive not less than 400 days compensation at the latest wage rate. This change is considered a post-employment benefits
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.029/2019 28 February 2019 Subject : Explanation of the change in operating results for the year 2018
) operating results based on its reviewed consolidated financial statements ended 31 March 2019 as follows. Highlights on Q1-2019 Operating results Unit : Million Baht Q1-19 Q1-18 Q4-18 % Change Amount % Amount
-9.30 -138.48 Change +/(-) Unit : million baht • Revenue of Q 1/2019 is less than of both Q 4/2018 and Q1/2018 because of the followings: o Low purchasing power in domestic market causes our domestic
. Statement of Comprehensive Income Total Revenues (Million Baht) Quarterly Change 1/2019 1/2018 % Sales Domestic Sales 88.4 106.6 (17.1) Export Sales 295.8 295.2 0.2 Total Sales 384.2 401.8 (4.4) Foreign
baht or 0.4 percent compared to non-current assets as of December 31, 2018. The major change was mainly from the decreased of investment property 0.9 million baht. 2 (2) Total Liabilities Company total
) operating results based on its reviewed consolidated financial statements ended 30 June 2019 as follows. Highlights on Q2-2019 Operating results Unit : Million Baht Q2-19 Q2-18 Q1-19 % Change Amount % Amount
-0.07 2.51 0.97 -0.90 -108.78 Change +/(-) Unit : million baht • The revenue of Q2/2019 is increased by 26.85 million baht comparing with Q1/2019 because higher revenue from both domestic market and
nearly the same, there is no significant change. Service Income In 2019, the company’s and subsidiaries’ service income was totally Baht 5.94 million, whereas none of them in 2018, increasing Baht 5.94
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech